I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immune-checkpoint inhibitor-associated diabetes compared to..:
Tittel, Sascha R
;
Laubner, Katharina
;
Schmid, Sebastian M
...
http://dx.doi.org/10.18725/OPARU-44171. , 2022
Link:
https://doi.org/10.18725/OPARU-44171
RT Journal T1
Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study
UL https://suche.suub.uni-bremen.de/peid=base-ftunivulm:oai:oparu.uni-ulm.de:123456789_44247&Exemplar=1&LAN=DE A1 Tittel, Sascha R A1 Laubner, Katharina A1 Schmid, Sebastian M A1 Kress, Stefan A1 Merger, Sigrun A1 Karges, Wolfram A1 Wosch, Frank J A1 Altmeier, Marcus A1 Pavel, Marianne A1 Holl, Reinhard W PB Universität Ulm YR 2022 K1 adverse effects K1 medication K1 multicenter registry K1 DDC 610 / Medicine & health K1 Cancer K1 Therapy K1 Neoplasms K1 Drug therapy K1 Drug-related side effects and adverse reactions K1 Endocrinology K1 Prevalence K1 Chemotherapie K1 Nebenwirkung JF http://dx.doi.org/10.18725/OPARU-44171 LK http://dx.doi.org/https://doi.org/10.18725/OPARU-44171 DO https://doi.org/10.18725/OPARU-44171 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)